The utero-placental circulation, eugenics and the prevention and treatment of high risk pregnancies.
Through systematic experimental and clinical studies, the physiological regulation of utero-placental circulation and the relation of the disturbance in this acirculation to pathogenic mechanisms of high risk pregnancies-Intrauterine Growth Retardation (IUGR) and Pregnancy-induced hypertension (PIH) were explored. The pharmacological effects and mechanism of a Chinese herbal medicine-Qingxintong in improving, the utero-placental circulation and the therapeutic efficacy in treatment of IUGR and PIH, both accompanied by disturbance of utero-placental circulation, were investigated as well.
Wu
X R
XR
Family Planning Research Institute, Tongji Medical University, Wuhan.
Li
Y
Y
Yang
D S
DS
Han
B J
BJ
Si
Y Z
YZ
Shan
Z Z
ZZ
Ma
T Y
TY
Wen
L Z
LZ
Sun
Y P
YP
Huang
Y P
YP
D000098:Acetophenones / Q000494:pharmacology* / Q000627:therapeutic use; D004365:Drugs, Chinese Herbal / Q000494:pharmacology* / Q000627:therapeutic use; D011464:Epoprostenol / Q000097:blood; D005260:Female; D005317:Fetal Growth Retardation / Q000517:prevention & control*; D006801:Humans; D021041:Placental Circulation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D011225:Pre-Eclampsia / Q000517:prevention & control*; D011247:Pregnancy; D018566:Pregnancy, High-Risk / Q000187:drug effects; D013928:Thromboxane A2 / Q000097:blood
D000098:Acetophenones; D004365:Drugs, Chinese Herbal; D010975:Platelet Aggregation Inhibitors; C032940:3,4-dihydroxyacetophenone; D013928:Thromboxane A2; D011464:Epoprostenol